KABI PHARMACIA AB has a total of 546 patent applications. Its first patent ever was published in 1977. It filed its patents most often in WIPO (World Intellectual Property Organization), Sweden and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ELILILLY AND COMPANY, PHARMACIA & UPJOHN AB and PHARMACIA AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 91 | |
#2 | Sweden | 83 | |
#3 | Canada | 56 | |
#4 | Australia | 47 | |
#5 | United States | 32 | |
#6 | South Africa | 28 | |
#7 | Norway | 19 | |
#8 | Ireland | 18 | |
#9 | Portugal | 17 | |
#10 | EPO (European Patent Office) | 16 | |
#11 | Hungary | 15 | |
#12 | New Zealand | 14 | |
#13 | Finland | 11 | |
#14 | Mexico | 8 | |
#15 | China | 7 | |
#16 | Republic of Korea | 7 | |
#17 | Lithuania | 7 | |
#18 | Russian Federation | 7 | |
#19 | Israel | 6 | |
#20 | Latvia | 6 | |
#21 | Brazil | 5 | |
#22 | Denmark | 5 | |
#23 | Romania | 4 | |
#24 | Slovakia | 4 | |
#25 | Czechia | 3 | |
#26 | Hong Kong | 3 | |
#27 | Japan | 3 | |
#28 | Netherlands | 3 | |
#29 | Poland | 3 | |
#30 | Taiwan | 3 | |
#31 | Bulgaria | 2 | |
#32 | Philippines | 2 | |
#33 | Singapore | 2 | |
#34 | Argentina | 1 | |
#35 | Belgium | 1 | |
#36 | Colombia | 1 | |
#37 | Germany | 1 | |
#38 | United Kingdom | 1 | |
#39 | Croatia | 1 | |
#40 | Malaysia | 1 | |
#41 | Ukraine | 1 | |
#42 | Yugoslavia (Serbia and Montenegro) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Machines | |
#5 | Medical technology | |
#6 | Environmental technology | |
#7 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Unspecified technologies | |
#6 | Syringes | |
#7 | Acyclic or carbocyclic compounds | |
#8 | Microorganisms | |
#9 | Climate change adaptation technologies | |
#10 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Hjertman Birger | 40 |
#2 | Ljungquist Olle | 35 |
#3 | Levander Gustav | 26 |
#4 | Lind Peter | 25 |
#5 | Resul Bahram | 20 |
#6 | Lake Mats | 20 |
#7 | Fryklund Linda | 19 |
#8 | Haraldsson Martin | 18 |
#9 | Holmgren Erik | 17 |
#10 | Ahrgren Leif | 17 |
Publication | Filing date | Title |
---|---|---|
US5691350A | Use of linomide for treatment of retrovirus infections specifically HIV infections | |
US5661008A | Recombinant human factor VIII derivatives | |
US5516796A | Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof | |
ZA9402035B | Protein formulation | |
WO9419186A1 | Autoclavable multilayer films | |
CA2113795A1 | Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof | |
LTIP1632A | New antibody-superantigen conjugates, process for preparing thereof, process for target cell lysis and use of conjugates in pharmaceutical compositions | |
WO9407920A1 | Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof | |
WO9407510A1 | Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer | |
ZA9307266B | Composition comprising coagulation factor VIII formulation process for its preparation and use of a surfactant as stabilizer | |
US5310913A | Derivatives of quinoline-3-carboxanilide | |
ZA9305045B | Pharmacologically active alfa-(tertiary-aminomethyl)-ben-zenemethanol derivatives | |
GB9313221D0 | Use of human igf-ii | |
WO9400434A1 | Novel nicotinic acid esters | |
KR100276374B1 | Dual-chamber injection cartridge | |
WO9321911A1 | Method and means for preventing constriction of the pupil in the eye | |
WO9320869A1 | Injection device | |
AU4273893A | Injection cartridge arrangement | |
NZ251498A | Injectable formulations of human growth hormone and citrate buffer | |
CA2091152A1 | Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof |